62653-26-3

Basic information

• Product Name: 2-AMINO-3,3-DIPHENYL-PROPIONIC ACID
• Synonyms: H-β,β-Diphenyl-DL-Ala-OH;DL-3,3-Diphenylalanine;H-b,b-Diphenyl-DL-Ala-OH;H-DL-Dip-OH;H-DL-ALA(3,3-DIPHENYL)-OH;H-DL-(3-PHENYL)PHE-OH;H-DL-DPH-OH;H-BETA,BETA-DIPHENYL-DL-ALA-OH
• CAS NO: 62653-26-3
• Molecular Formula: C₁₅H₁₅NO₂
• Molecular Weight: 241.29
• Mol File: 62653-26-3.mol
• Article Data: 5

Chemical Properties

• Melting Point: 236 °C (decomp)
• Boiling Point: 389.2 °C at 760 mmHg
• Flash Point: 189.2 °C
• Appearance: /
• Density: 1.198g/cm³
• Vapor Pressure: 9.35E-07mmHg at 25°C
• Refractive Index: 1.611
• Storage Temp.: Store at RT.
• PKA: 2.11±0.10(Predicted)
• CAS DataBase Reference: 2-AMINO-3,3-DIPHENYL-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-3,3-DIPHENYL-PROPIONIC ACID(62653-26-3)
• EPA Substance Registry System: 2-AMINO-3,3-DIPHENYL-PROPIONIC ACID(62653-26-3)

Safety Data

• Hazardous Substances Data: 62653-26-3(Hazardous Substances Data)

Usage

General Description

2-Amino-3,3-diphenyl-propionic acid is a chemical compound with the molecular formula C15H15NO2. It is a white crystalline powder that is classified as a non-proteinogenic amino acid. 2-AMINO-3,3-DIPHENYL-PROPIONIC ACID is typically used in the production of pharmaceuticals and organic synthesis. It has also been studied for its potential role as an inhibitor of the enzyme dipeptidyl peptidase-IV, which is involved in the regulation of blood sugar levels. Additionally, it has been investigated for its antiparasitic and antimicrobial properties. Overall, 2-amino-3,3-diphenyl-propionic acid has the potential to be utilized in a variety of therapeutic and industrial applications.

InChI:InChI=1/C15H15NO2/c16-14(15(17)18)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13-14H,16H2,(H,17,18)

Upstream product

• 10034-85-2 hydrogen iodide 
• 108-24-7 acetic anhydride 
• 270078-91-6 5-(diphenylmethyl)imidazolidine-2,4-dione 
• 947-91-1 Diphenylacetaldehyde 

Downstream Products

• 3963-62-0 2,2-Diphenylethylamine 
• 149597-92-2 (S)-β,β-diphenyl-α-alanine 
• 149597-91-1 (2R)-3,3-diphenylalanine 
• 189567-30-4 2-(3-Nitro-6-methoxy-2-pyridinylamino)-3,3-diphenylpropionic acid 
• 189567-25-7 3,3-Diphenyl-2-(4,6-dimethyl-2-pyrimidinylamino)propionic acid 
• 107202-40-4 (R,S)-2-(t-boc-amino)-3,3-dicyclohexylpropan-1-ol 
• 107202-37-9 (1-hydroxymethyl-2,2-diphenyl-ethyl)-carbamic acid tert-butyl ester 
• 839719-72-1 2-(9H-fluoren-9-ylmethoxycarbonylamino)-3,3-diphenyl-propionic acid 
• 93406-82-7 ethyl 2-amino-3,3-diphenylpropanoate 
• 92646-33-8 2-amino-3,3-diphenyl-1-propanol 

Relevant articles and documents

Immunomodulatory peptides

The invention relates to peptides derivatized with a hydrophilic polymer which, in some embodiments, bind to human FcRn and inhibit binding of the Fc portion of an IgG to an FcRn, thereby modulating serum IgG levels. The disclosed compositions and methods may be used in some embodiments, for example, in treating autoimmune diseases and inflammatory disorders. The invention also relates, in further embodiments, to methods of using and methods of making the peptides of the invention.

Substituted quinoxaline-2-ones as glutamate receptor antagonists

A novel series of substituted quinoxaline 2-ones useful as neuroprotective agents are taught. Novel intermediates, processes of preparation, and pharmaceutical compositions containing the compounds are also taught. The compounds are glutamate receptor antagonists and are useful in the treatment of stroke, cerebral ischemia, or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia, seizure disorders, pain, Alzheimer's, Parkinson's, and Huntington's Diseases.

Hydrophobic peptides

Hydrophobic peptides having antihypertensive activity are disclosed. Also disclosed are pharmaceutical compositions comprising a hydrophobic peptide and a method of treatment of mammalian hypertension comprising administering a hydrophobic peptide to a hy